Earnings History Data for Werewolf Therapeutics (HOWL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Werewolf Therapeutics

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		HOWL	Werewolf Therapeutics	99.00	-0.38	-0.41	0.00		2.25	-0.19 (-7.82%)	0.0	0.0 (0.00%)	1.66 - 8.19	801,822	840,000	0

03-05-2024	PM		HOWL	Werewolf Therapeutics	261.00	-0.39	-0.35	0.00	Werewolf Therapeutics GAAP EPS of -$0.39, revenue of $0.74M [5/3/2024 7:34 AM]	6.00	-0.08 (-1.32%)	6.39	0.31 (5.10%)	1.57 - 8.19	125,105	160,000	1,406
Werewolf Therapeutics GAAP EPS of -$0.39, revenue of $0.74M [5/3/2024 7:34 AM]
07-03-2024	PM		HOWL	Werewolf Therapeutics	278.00	-0.33	-0.43	0.00	Werewolf Therapeutics GAAP EPS of -$0.33, revenue of $1.5M [3/7/2024 11:27 AM]	6.74	-0.29 (-4.13%)	0.0	0.0 (0.00%)	1.57 - 8.19	173,232	210,000	0
Werewolf Therapeutics GAAP EPS of -$0.33, revenue of $1.5M [3/7/2024 11:27 AM]
14-11-2023	AH		HOWL	Werewolf Therapeutics	82.00	-0.23	-0.27	0.00	Werewolf Therapeutics GAAP EPS of -$0.23, revenue of $5.9M [11/14/2023 5:02 PM]	2.18	-0.02 (-0.91%)	2.28	0.08 (3.64%)	1.39 - 4.57	165,580	4,680,000	10,972
Werewolf Therapeutics GAAP EPS of -$0.23, revenue of $5.9M [11/14/2023 5:02 PM]
11-05-2023	PM		HOWL	Werewolf Therapeutics	106.00	-0.34	-0.49	0.00		2.78	-0.26 (-8.55%)	0.0	0.0 (0.00%)	1.39 - 7.51	17,499	40,000	0

10-11-2022	PM	7:00 AM ET (Nov 10)	HOWL	Werewolf Therapeutics, Inc.	70.28	-0.40	-0.60	-0.51	Werewolf Therapeutics GAAP EPS of -$0.40 beats by $0.20, revenue of $4.97M beats by $0.9M [11/10/2022 9:26 AM]	2.29	0.07 (3.38%)	0.0	0.0 (0.00%)	2.16 - 16.50	24,485	80,000	0
Werewolf Therapeutics GAAP EPS of -$0.40 beats by $0.20, revenue of $4.97M beats by $0.9M [11/10/2022 9:26 AM] Werewolf Therapeutics Presents Preclinical Data on mWTX-330, a Surrogate IL-12 INDUKINE Molecule, at the Society for Immunotherapy of Cancer Annual Meeting [Nov-10-22 09:00AM] Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-10-22 07:00AM]
10-05-2022	PM	7:00 AM ET (May 10)	HOWL	Werewolf Therapeutics	145.00	-0.56	-0.60	0.00	Werewolf Therapeutics GAAP EPS of -$0.56 beats by $0.05 [5/10/2022 7:55 AM]	6.10	0.71 (13.16%)	5.59	0.20 (3.71%)	3.51 - 21.67	144,083	339,035	129
Werewolf Therapeutics GAAP EPS of -$0.56 beats by $0.05 [5/10/2022 7:55 AM] Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights [May-10-22 07:00AM]
24-03-2022	PM		HOWL	Werewolf Therapeutics, Inc.	117.49	-0.66	-0.56	0.00	Werewolf Therapeutics GAAP EPS of -$0.66 misses by $0.10 [3/24/2022 7:28 AM]	3.63	-0.25 (-6.44%)	3.90	0.02 (0.52%)	3.51 - 23.99	82,524	71,040	242
Werewolf Therapeutics GAAP EPS of -$0.66 misses by $0.10 [3/24/2022 7:28 AM] Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Highlights [Mar-24-22 07:00AM]
10-11-2021	PM		HOWL	Werewolf Therapeutics	433.00	-0.51	-0.45	0.00	Werewolf Therapeutics reports Q3 results [11/10/2021 9:06 AM]	16.01	0.28 (1.78%)	0.0	0.0 (0.00%)	11.23 - 23.99	18,668	40,000	0
Werewolf Therapeutics reports Q3 results [11/10/2021 9:06 AM] Werewolf Therapeutics Reports Third Quarter 2021 Financial Results and Business Update [Nov-10-21 07:00AM]
12-08-2021	PM	7:00 AM ET (Aug 12)	HOWL	Werewolf Therapeutics, Inc.	413.00	-3.82	-0.28	0.00	Werewolf Therapeutics EPS misses by $3.55 [8/12/2021 8:47 AM]	15.22	0.25 (1.67%)	15.22	0.0 (0.00%)	11.23 - 23.99	25,036	20,000	637
Werewolf Therapeutics EPS misses by $3.55 [8/12/2021 8:47 AM] Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update [Aug-12-21 07:00AM]